Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BTAI Bioxcel Therapeutics Inc.

交易中 05-02 14:06:55 EDT

2.55

+0.01

+0.39%

最高2.58	最低2.50	成交量9.98万
今开2.54	昨收2.54	日振幅3.15%
总市值9,444万	流通市值6,235万	总股本3,703万
成交额25.29万	换手率0.41%	流通股本2,445万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":2.55,"timestamp":1714673177342,"preClose":2.54,"halted":0,"volume":99771,"delay":0,"floatShares":24449932,"shares":37034517,"eps":-6.146898,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"05-02 14:06:55 EDT","open":2.54,"high":2.58,"low":2.5,"amount":252902.42415900002,"amplitude":0.031496,"askPrice":2.56,"askSize":1471,"bidPrice":2.55,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-6.146898,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714680000000},"adr":0,"listingDate":1520485200000,"adjPreClose":2.54,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.5897,"preClose":2.54,"latestTime":"09:13 EDT","volume":100,"amount":258.97,"timestamp":1714655631353},"postHourTrading":{"tag":"盘后","latestPrice":2.54,"preClose":2.54,"latestTime":"17:24 EDT","volume":47629,"amount":120978.07,"timestamp":1714598692887},"volumeRatio":0.42802},"requestUrl":"/m/hq/s/BTAI","defaultTab":"news","newsList":[{"id":"2430824522","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.35%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430824522","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430824522?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:32","pubTimestamp":1714055576,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速跳水5.35%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.69%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申BioXcel Therapeutics评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522325679237b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522325679237b6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429119167","title":"Bioxcel Therapeutics, Inc.盘中异动 急速上涨5.26%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119167","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429119167?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:56","pubTimestamp":1713884167,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时56分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速拉升5.26%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申BioXcel Therapeutics评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322560787e82dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322560787e82dd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429670201","title":"HC Wainwright & Co.：重申BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429670201","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429670201?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:36","pubTimestamp":1713868586,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318362887a5c895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318362887a5c895&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428665777","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨5.10%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428665777","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428665777?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:17","pubTimestamp":1713536262,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时17分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。截至发稿，该股报2.68美元/股，成交量12.5851万股，换手率0.41%，振幅5.80%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation、艾吉纳斯涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为177.17%、9.50%、7.41%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Portage Biotech Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为34.28%、27.12%、23.85%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192217427a541f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192217427a541f73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426994612","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426994612","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426994612?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:46","pubTimestamp":1712861171,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日02时46分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速拉升5.32%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为823.84%、622.11%、523.28%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120246127a5231f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120246127a5231f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419970613","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419970613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419970613?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:06","pubTimestamp":1710511618,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时06分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下挫5.05%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Better Therapeutics, Inc.、杰龙、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为210.07%、71.60%、17.27%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为94.29%、63.00%、49.00%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031522065887e795c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031522065887e795c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418373925","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨7.93%报3.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418373925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418373925?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:32","pubTimestamp":1710250329,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅拉升7.93%。截至发稿，该股报3.13美元/股，成交量22.773万股，换手率0.75%，振幅7.24%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm  Plc涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为150.20%、127.39%、27.47%，振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited，振幅分别为34.35%、13.07%、12.26%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122132098b290a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122132098b290a6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418533805","title":"BUZZ-BioXcel Therapeutics 因第四季度亏损收窄而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2418533805","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418533805?lang=zh_cn&edition=full","pubTime":"2024-03-12 19:59","pubTimestamp":1710244750,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月12日 - ** BioXcel Therapeutics   股价盘前上涨6.9%至3.10美元** (link)，第四季度亏损收窄，为每小时76美分，去年同期为每小时1.95美元。** 然而，该公司第四季度的利润为 37.6 万美元，低于华尔街预计的 71.1 万美元 - LSEG 数据** 截至上次收盘，公司股价在过去12个月中下跌了86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417057727","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨5.26%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417057727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417057727?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:40","pubTimestamp":1709908807,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时40分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅上涨5.26%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Cero Therapeutics Holdings, Inc.涨幅较大，Scisparc Ltd.、Quoin Pharmaceuticals Ltd、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为208.15%、179.81%、44.40%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、知临集团、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为110.25%、40.92%、35.71%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822400787e77534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822400787e77534&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417053498","title":"BioXcel Therapeutics Inc   预计每股亏损91美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2417053498","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417053498?lang=zh_cn&edition=full","pubTime":"2024-03-08 20:50","pubTimestamp":1709902212,"startTime":"0","endTime":"0","summary":"   * BioXcel Therapeutics Inc    将于3月12日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于康涅狄格州纽黑文的公司的营收预计将从一年前的23.8万美元增长198.8%，达到711.13万美元。* LSEG 分析师对 BioXcel Therapeutics Inc 的平均预期是每股亏损 91 美分。* 华尔街对 BioXcel Therapeutics Inc 的 12 个月目标价中位数为 11.50 美元，高于其上一次收盘价 3.04 美元。3月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411630273","title":"BUZZ-BioXcel Therapeutics 公司取消股票发行后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2411630273","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411630273?lang=zh_cn&edition=full","pubTime":"2024-02-13 23:10","pubTimestamp":1707837030,"startTime":"0","endTime":"0","summary":"    2月13日 - ** BioXcel Therapeutics公司  终止6000万美元的股票发行计划，股价周二早盘上涨9.5%，报2.14美元。** 生物制药公司称，目前的市场条件不利于 ，不利于符合股东最佳利益的股票发行。** 周一，该公司称美国食品及药物管理局授予其前列腺癌疗法  \"快速通道 \"资格** 周五，BTAI 大跌  ~44%，创该公司在周四收盘后发行股票后的历史新低。** 即使本交易日有所上涨，BTAI 在 2024 年初仍下跌约 27%，在过去一年中下跌超过 90","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410272840","title":"Bioxcel Therapeutics Inc盘中异动 股价大涨11.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410272840","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410272840?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:31","pubTimestamp":1707748272,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时31分，Bioxcel Therapeutics Inc股票出现异动，股价急速上涨11.96%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Revelation Biosciences Inc C/Wts 10/01/2027 、Cymabay Therapeutics Inc涨幅较大，Kintara Therapeutics Inc、Tc Biopharm  Plc、Cymabay Therapeutics Inc较为活跃，换手率分别为90.08%、47.88%、13.00%，振幅较大的相关个股有Intensity Therapeutics Inc、依生生物、Equillium Inc，振幅分别为10.56%、9.55%、9.08%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212223113878a0e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212223113878a0e99&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410405668","title":"嗡嗡声--美国股票走势-Diamondback、Rivian Automotive、BioXcel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2410405668","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410405668?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:23","pubTimestamp":1707747784,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月12日 - 继前一周强劲收盘后，周一美国股指期货表现低迷，市场关注一系列经济数据，这些数据可能会消除降息前景的一些不确定性。美东时间9:01，道指电子盘  下跌0.10%，报38,710点。标准普尔500指数小型股  下跌0.03%，报5,042.25点；纳斯达克100指数小型股  下跌0.05%，报18,029.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410842006","title":"BUZZ-BioXcel 因前列腺癌疗法获得 FDA \"快速通道 \"标签而崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2410842006","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410842006?lang=zh_cn&edition=full","pubTime":"2024-02-12 21:49","pubTimestamp":1707745755,"startTime":"0","endTime":"0","summary":"    2月12日 - ** BioXcel Therapeutics   股价盘前上涨10%至2.32美元 ** 该公司称，美国食品和药物管理局 已授予其正在开发的治疗一种前列腺癌的实验性组合疗法 \"快速通道 \"资格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409433153","title":"Bioxcel Therapeutics Inc盘中异动 早盘股价大涨8.17%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409433153","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409433153?lang=zh_cn&edition=full","pubTime":"2024-02-05 22:31","pubTimestamp":1707143476,"startTime":"0","endTime":"0","summary":"北京时间2024年02月05日22时31分，Bioxcel Therapeutics Inc股票出现异动，股价快速上涨8.17%。截至发稿，该股报3.31美元/股，成交量50.2759万股，换手率1.68%，振幅2.22%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.16%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223116877165ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223116877165ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408594868","title":"Bioxcel Therapeutics Inc盘中异动 临近收盘股价大跌5.28%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408594868","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408594868?lang=zh_cn&edition=full","pubTime":"2024-02-01 04:53","pubTimestamp":1706734431,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日04时53分，Bioxcel Therapeutics Inc股票出现波动，股价大幅下跌5.28%。截至发稿，该股报3.23美元/股，成交量28.6801万股，换手率0.96%，振幅6.16%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，2Seventy Bio Inc、Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Revelation Biosciences Inc、Kintara Therapeutics Inc、Ensysce Biosciences Inc较为活跃，换手率分别为881.51%、703.72%、568.68%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Psyence Biomedical Ltd、Neximmune Inc，振幅分别为90.24%、69.63%、66.53%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020104535287e6aade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020104535287e6aade&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407367494","title":"Bioxcel Therapeutics Inc盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407367494","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407367494?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:55","pubTimestamp":1706633742,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日00时55分，Bioxcel Therapeutics Inc股票出现波动，股价急速上涨5.10%。截至发稿，该股报3.61美元/股，成交量24.1165万股，换手率0.81%，振幅7.73%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Neximmune Inc、Gri Bio Inc、Pepgen Inc涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Iterum Therapeutics Plc较为活跃，换手率分别为1206.08%、248.16%、167.66%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Pepgen Inc，振幅分别为800.00%、218.65%、61.72%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013100554387e69e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013100554387e69e58&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406969637","title":"Bioxcel Therapeutics Inc盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406969637","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406969637?lang=zh_cn&edition=full","pubTime":"2024-01-26 22:38","pubTimestamp":1706279930,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日22时38分，Bioxcel Therapeutics Inc股票出现波动，股价快速上涨5.02%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Ys Biopharma Co Ltd C/Wts 15/03/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Tc Biopharm  Plc、Processa Pharmaceuticals Inc、Jaguar Health Inc较为活跃，换手率分别为921.11%、484.18%、102.30%，振幅较大的相关个股有Dermata Therapeutics Inc、Vera Therapeutics  Inc.、Cyclerion Therapeutics Inc，振幅分别为19.89%、16.28%、15.71%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126223850790c7ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126223850790c7ea2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402470622","title":"Bioxcel Therapeutics Inc盘中异动 股价大跌5.13%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402470622","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402470622?lang=zh_cn&edition=full","pubTime":"2024-01-12 00:15","pubTimestamp":1704989712,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日00时15分，Bioxcel Therapeutics Inc股票出现波动，股价快速跳水5.13%。截至发稿，该股报2.59美元/股，成交量19.4381万股，换手率0.66%，振幅3.66%。Bioxcel Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Atreca Inc、Surrozen Inc C/Wts 01/08/2031 、Sagimet Biosciences Inc涨幅较大，Atreca Inc、Clearmind Medicine Inc、Neximmune Inc较为活跃，换手率分别为388.85%、277.61%、57.74%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Atreca Inc、Moolec Science Sa C/Wts ，振幅分别为71.43%、59.29%、46.75%。Bioxcel Therapeutics Inc公司简介：BioXcel Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011200151379082714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011200151379082714&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioxceltherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0627},{"period":"1month","weight":-0.0993},{"period":"3month","weight":-0.2013},{"period":"6month","weight":-0.4526},{"period":"1year","weight":-0.8778},{"period":"ytd","weight":-0.139}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioxcel Therapeutics, Inc.于2017年3月29日成为特拉华州公司，为BioXcel的全资附属公司。 BioXcel Therapeutics，Inc.或BTI是一家临床阶段的生物制药公司，专注于药物开发，利用新型人工智能或人工智能识别神经科学和免疫肿瘤学领域的下一波药物。他们的药物再创新方法利用现有批准的药物或经临床验证的产品候选药物以及大数据和专有机器学习算法来确定新的治疗指标。他们的两个最先进的临床开发项目是BXCL501，一种a2a肾上腺素能受体激动剂右美托咪定或Dex的舌下薄膜制剂，用于急性治疗由神经和精神疾病引起的激动，和BXCL701，一种用于治疗罕见形式的前列腺癌和胰腺癌。他们在2017年12月开始使用Dex在轻度可能AD中的IV制剂的1b期药代动力学/药效学或PK / PD安全性研究，并且他们计划在精神分裂症患者中使用Dex的IV制剂开始1b期药代动力学/药效学安全性研究，他们期望在2018年下半年报告这两项研究的数据。他们还打算在2018年开始两项计划的第二阶段概念证明或PoC开放标签临床试验。他们预计，到2018年底，计划在BXCL501计划的阶段2 PoC开放标签临床试验中提供的数据读数将可用。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.129318},{"month":2,"riseRate":0.833333,"avgChangeRate":0.365471},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.136546},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016546},{"month":5,"riseRate":0.571429,"avgChangeRate":0.064824},{"month":6,"riseRate":0.5,"avgChangeRate":-0.103306},{"month":7,"riseRate":0.5,"avgChangeRate":0.058901},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.137488},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.136967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.013323},{"month":11,"riseRate":0.333333,"avgChangeRate":0.076409},{"month":12,"riseRate":0.5,"avgChangeRate":0.192882}],"exchange":"NASDAQ","name":"Bioxcel Therapeutics Inc.","nameEN":"Bioxcel Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bioxcel Therapeutics Inc.,BTAI,Bioxcel Therapeutics Inc.股票,Bioxcel Therapeutics Inc.股票老虎,Bioxcel Therapeutics Inc.股票老虎国际,Bioxcel Therapeutics Inc.行情,Bioxcel Therapeutics Inc.股票行情,Bioxcel Therapeutics Inc.股价,Bioxcel Therapeutics Inc.股市,Bioxcel Therapeutics Inc.股票价格,Bioxcel Therapeutics Inc.股票交易,Bioxcel Therapeutics Inc.股票购买,Bioxcel Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}